Get Premium to unlock powerful stock data
NYSE:BHC (Canada)  
Bausch Health Companies Inc logo

Bausch Health Companies Inc

$ 8.53 +0.17 (+2.03%) 08:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 3.02B
Enterprise V:
$ 24.94B
Volume:
3.43M
Avg Vol (2M):
8.60M
Also Trade In:
Volume:
3.43M
Market Cap $:
3.02B
PE Ratio:
At Loss
Avg Vol (2-Month):
8.60M
Enterprise Value $:
24.94B
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Bausch Health Companies Inc
NAICS : 325412 SIC : 3741
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Description
Formerly known as Valeant Pharmaceuticals, Bausch Health is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Bausch+Lomb (45% of revenue), Salix Pharmaceuticals (24%), international pharma (14%), ortho dermatology (7%), and diversified products (10%). Bausch is the market leader in consumer visioncare in India and China and the fourth-largest visioncare company by sales in the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 0.05
Equity-to-Asset -0.01
Debt-to-Equity -107.26
Debt-to-EBITDA 9.61
Interest Coverage 0.69
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.06
Distress
Grey
Safe
Beneish M-Score -2.65
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 59.81
9-Day RSI 51.42
14-Day RSI 42.46
6-1 Month Momentum % -65.34
12-1 Month Momentum % -68.16

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.22
Quick Ratio 1
Cash Ratio 0.26
Days Inventory 161.8
Days Sales Outstanding 71.72
Days Payable 65.16

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.9

Financials (Next Earnings Date:2022-08-03 Est.)

BHC's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NYSE:BHC

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 8,325
EPS (TTM) ($) -1.14
Beta 1.55
Volatility % 53.87
14-Day RSI 42.46
14-Day ATR ($) 0.61786
20-Day SMA ($) 8.1745
12-1 Month Momentum % -68.16
52-Week Range ($) 6.88 - 30.3
Shares Outstanding (Mil) 361.48

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bausch Health Companies Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More